ArticleHuman mutation2026

Combined Nivolumab and Ipilimumab Therapy Promotes Immune-Mediated Cardiomyocyte Apoptosis Through TLR4-Myd88-NF-

Mengjiao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.